SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

SAN

87.36

-5.12%↓

MRK1

116.2

+1%↑

SHL.DE

46.58

-0.98%↓

ARGX

505.8

-1.21%↓

FRE

43.06

+1.25%↑

Search

Orion Oyj (Class B)

Chiusa

58.7 1.29

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

58.6

Massimo

58.8

Metriche Chiave

By Trading Economics

Entrata

-12M

61M

Vendite

-80M

355M

P/E

Media del settore

23.508

53.54

EPS

0.44

Rendimento da dividendi

2.81

Margine di Profitto

17.287

Dipendenti

3,943

EBITDA

136M

202M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

2.81%

2.44%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.7B

8.2B

Apertura precedente

57.41

Chiusura precedente

58.7

Orion Oyj (Class B) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

31 mag 2025, 10:30 UTC

Notizie principali

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 mag 2025, 06:30 UTC

Utili

5 Things We've Learned From Retail Earnings -- Barrons.com

31 mag 2025, 04:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

30 mag 2025, 23:51 UTC

Acquisizioni, Fusioni, Takeovers

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 mag 2025, 21:30 UTC

Notizie principali

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 mag 2025, 21:15 UTC

Notizie principali

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 mag 2025, 20:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

30 mag 2025, 20:44 UTC

Acquisizioni, Fusioni, Takeovers

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 mag 2025, 20:24 UTC

Notizie principali

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 mag 2025, 20:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

30 mag 2025, 19:44 UTC

Discorsi di Mercato

Gold Breaks 4-Month Winning Streak -- Market Talk

30 mag 2025, 19:38 UTC

Discorsi di Mercato

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 mag 2025, 19:29 UTC

Utili
Acquisizioni, Fusioni, Takeovers

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 mag 2025, 19:14 UTC

Discorsi di Mercato

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 mag 2025, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 mag 2025, 18:51 UTC

Discorsi di Mercato

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 mag 2025, 18:37 UTC

Discorsi di Mercato
Utili

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 mag 2025, 18:04 UTC

Notizie principali

S&P 500 Falls After More Trump-China Friction -- WSJ

30 mag 2025, 17:47 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

30 mag 2025, 17:47 UTC

Discorsi di Mercato

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 mag 2025, 17:40 UTC

Acquisizioni, Fusioni, Takeovers

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 mag 2025, 17:38 UTC

Discorsi di Mercato

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 mag 2025, 17:31 UTC

Discorsi di Mercato

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 mag 2025, 17:14 UTC

Notizie principali

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 mag 2025, 16:31 UTC

Utili

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 mag 2025, 16:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

30 mag 2025, 16:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

30 mag 2025, 16:16 UTC

Notizie principali

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 mag 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

30 mag 2025, 16:14 UTC

Notizie principali

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Confronto tra pari

Modifica del prezzo

Orion Oyj (Class B) Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.